Vaxxinity Ownership
VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Vaxxinity |
Vaxxinity Pink Sheet Ownership Analysis
About 51.0% of the company outstanding shares are owned by insiders. The book value of Vaxxinity was at this time reported as 0.11. The company has Price/Earnings To Growth (PEG) ratio of 0.05. Vaxxinity recorded a loss per share of 0.45. The entity had not issued any dividends in recent years. Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.The quote for Vaxxinity is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Mei JD at 254 244 5739 or visit https://www.vaxxinity.com.Vaxxinity Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vaxxinity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vaxxinity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vaxxinity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hornig George R over six months ago Acquisition by Hornig George R of 129187 shares of Vaxxinity subject to Rule 16b-3 | ||
Blatt Gregory R over six months ago Acquisition by Blatt Gregory R of 129187 shares of Vaxxinity at 2.09 subject to Rule 16b-3 | ||
United Biomedical Inc over a year ago Purchase by United Biomedical Inc of 100000 shares of Vaxxinity | ||
Prime Movers Lab Fund I Lp over a year ago Sale by Prime Movers Lab Fund I Lp of 1251 shares of Vaxxinity | ||
Smith James Alan over a year ago Acquisition by Smith James Alan of 132352 shares of Vaxxinity subject to Rule 16b-3 | ||
Reese Lou over a year ago Vaxxinity exotic insider transaction detected | ||
Smith James Alan over a year ago Vaxxinity exotic insider transaction detected | ||
Reese Lou over a year ago Acquisition by Reese Lou of 620000 shares of Vaxxinity subject to Rule 16b-3 | ||
Smith James Alan over a year ago Vaxxinity exotic insider transaction detected |
Vaxxinity's latest congressional trading
Congressional trading in companies like Vaxxinity, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Vaxxinity by those in governmental positions are based on the same information available to the general public.
2024-01-19 | Senator Rick Scott | Acquired Under $15K | Verify | ||
2024-01-18 | Senator Rick Scott | Acquired Under $15K | Verify |
Vaxxinity Outstanding Bonds
Vaxxinity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vaxxinity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vaxxinity bonds can be classified according to their maturity, which is the date when Vaxxinity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |